kitol: one of provitamins A; alpha particle bombardment with radon effects the conversion of kitol to vitamin A; occurs in variety of fish liver oils & in livers of oxen & sheep; RN given refers to (1alpha,2alpha,5alpha(1E,3E),6beta(1E,3E,5E))-isomer; kitol A & kitol B are geometrically isomeric components of kitol; structure of kitol in first source; structure of kitols A & B in second source
ID Source | ID |
---|---|
PubMed CID | 6441296 |
SCHEMBL ID | 11474186 |
MeSH ID | M0051924 |
Synonym |
---|
kitol |
[(1s,4s,5r,6r)-6-(hydroxymethyl)-2,5-dimethyl-4-[(1e,3e)-2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)buta-1,3-dienyl]-5-[(1e,3e,5e)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hexa-1,3,5-trienyl]cyclohex-2-en-1-yl]methanol |
kitol a |
kitol b |
unii-111cfg4v2b |
3,6-dimethyl-5-(2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadienyl)-6-(4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-yl)-1,3,5-hexatrienyl)-3-cyclohexene-1,2-dimethanol |
111cfg4v2b , |
4626-00-0 |
SCHEMBL11474186 |
kitol [mi] |
3-cyclohexene-1,2-dimethanol, 3,6-dimethyl-5-((1e,3e)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadienyl)-6-((1e,3e,5e)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3,5-hexatrienyl)-, (1r,2s,5s,6r)-rel- |
22555-09-5 |
rel-((1r,2s,5s,6r)-3,6-dimethyl-5-((1e,3e)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)buta-1,3-dien-1-yl)-6-((1e,3e,5e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexa-1,3,5-trien-1-yl)cyclohex-3-ene-1,2-diyl)dimethanol |
DTXSID801017010 |
[6-(hydroxymethyl)-2,5-dimethyl-4-[(1e,3e)-2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)buta-1,3-dienyl]-5-[(1e,3e,5e)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hexa-1,3,5-trienyl]cyclohex-2-en-1-yl]methanol |
Q27251210 |
AKOS040752262 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (37.37) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |